Great work James!!

MCW Cancer Center is hiring cancer docs! Interested in joining a rapidly growing, mission driven and research oriented cancer team? We have new positions open for thoracic, gastrointestinal and hematologic/heme malignancy specialists. DM me or email [email protected]

In October 2017, we treated our first patient on a dose-escalation Phase 1 trial with bispecific anti-CD20/anti-CD19 CAR-T cell product utilizing a point-of-care manufacturing system. Many early skeptics, multiple grant rejections. Our team persevered!

Big shout out 🙏🏾 to Ruben Mesa Ruben A. Mesa, MD for the kind invitation & graciously hosting & bringing us together at 13th Biennial Joyce Niblak MPN Meeting Phoenix AZ 👏🏽 allowing us to raise awareness about MPNs L➡️R Ruben A. Mesa, MD Dr Laura C. Michaelis Naveen Pemmaraju, MD & Dr John Mascarenhas | #MPNSM

Stop by our MCL poster Tim Fenske will be presenting tonight! 10 patients with R/R MCL s/p bispecific CAR20.19 T cells. ORR 100%, no relapses to date, median follow up 20 months! Mehdi Hamadani, MD #ASH22

Long line at #ASH22 Power Nap kiosk — maybe important endpoint when measuring efficacy of Sunday night parties? #docswhonap #dontshamesleep

Fabulous #mentorship on display during the #AMLsm oral session 616 today #ASH22 . I want to call out Tapan Kadia mentoring Patrick Reville, MD, MPH, Dr. Martinelli mentoring Dr. Marconi, Dr. Wei mentoring Dr. Chong Chyn Chua just from this session. This is what ASH is about.

#ASH22 . After single induction (7+3), for residual disease, lower intensity re-induction (Ven/HMA) was feasible and comparable to another cycle of 7+3, leading to less time in the hospital, NF and transfusions. MCW experience, but now a widespread practice.

Such exciting data for patients with CALRmut MPNs. A great example of how industry-academia collaborations can accelerate development of novel therapies. Lovely work from Edimara Reis and colleagues Incyte Hitchcock Lab Plo isabelle and others

Awesome socializing with Dr. Uma Borate: Associate Professor Amy DeZern and the phenomenal Dr. Garcia. #ASH22 #doctorsinglitter So fun!

Sameem Abedin presenting on Lintuzumab - great study! Medical College of Wisconsin #ASH22

Never dreamed when I started my career that hematology would give me one of the best friends I’ve ever had…
So grateful for you Heidi Klepin!

#ASH22 night 1. So lucky to call these #WomenInLeukemia friends and colleagues. ⁦Eunice Wang MD⁩ ⁦Laura C. Michaelis⁩ Dr. Courtney DiNardo of ⁦MD Anderson Cancer Center⁩, and Dr. Kristen O’Dwyer of ⁦University of Rochester⁩. #AMLsm #ALLsm ⁦ASH⁩ 🧡

ASH wants to ensure the health & safety of all #ASH22 attendees in New Orleans ⚜️ Do your part by reviewing this year's protocols on vaccinations, masking requirements, COVID-19 testing, & more: loom.ly/_mT5VbQ

Check out the 🧵⬇️ for a protocol prep tweetorial!

Shaji Kumar Named Editor-in-Chief of The Hematologist - Hematology.org - So excited for the next chapter of this great publication. Thanks ⁦Shaji Kumar⁩ for taking the reins. hematology.org/newsroom/press…

Super comprehensive & thought provoking talks on CMML needing it’s own space. #TXMPN22 #CMML Eric Padron MD Mrinal Patnaik 👏🏽

The Original “OG” MPN Cowboys #DickSilver and #JerrySpivak at #TXMPN22 see y’all at their MPN Congress soon in NYC! ⁦Naveen Pemmaraju, MD⁩ ⁦VJHemOnc⁩ ⁦Laura C. Michaelis⁩ ⁦Andrew Kuykendall MD⁩ ⁦MPN Research Foundation⁩ ⁦Abdulraheem Yacoub⁩ ⁦Stephen Oh⁩ ⁦David Steensma, MD⁩

Learning a lot about clinical trial design with a great group of leukemia enthusiasts/physicians! PDG 08 AACR ASCO Methods in Clinical Cancer Research Workshop 2022

Heads Up! Medical College of Wisconsin is looking for interested folks to join our rapidly growing heme/onc division as oncologic hospitalists. Great colleagues, diverse research opportunities. Interested? DM me or reach out to Kim at 414-805-4600.

Excited to present on frontline therapies of #CLL at MCW Hematologic Malignancies Symposium Medical College of Wisconsin
🙏🏽🙏🏽Thank you Mehdi Hamadani, MD Laura C. Michaelis Drs Atallah Dr Guru Murthy